Navigation Links
Dimension One Spas Offers Dealer Sales Training
Date:1/4/2014

Vista, CA (PRWEB) January 04, 2014

Dimension One Spas (D1) is hosting two dealer sales trainings coming up in Orlando, FL on January 9th 2014 and San Antonio, TX on January 15th. These national spa training sessions are designed to give dealers a jump start in the New Year with defined goals and refreshed tools. It’s also a great time for new dealers to get official D1 sales training before the hot tub season begins in March.

These one-day power sessions include class time with extensive product training, in-depth sales and closing, final exam and awards. Attendees who complete, will earn the title, “Certified Spa Consultant” as a part of the D1 training curriculum. Dealers who attend will also be even more prepared for D1 Spas’ Annual Dealer Retreat in La Jolla, CA, taking place in early February.

For more information on D1’s national sales training sessions, email Robert Randall at rrandall(at)d1spas(dot)com

###
About Dimension One Spas
Dimension One Spas (D1), founded in 1977, is the industry leader in designing and manufacturing luxury home hot tub hydrotherapy and aquatic fitness products. D1 has combined its innovations in materials, science and water technology to bring customers the most advanced spas in the world. D1 has created a benchmark for quality and innovation, offering four distinct high performance collections. Please visit http://www.d1spas.com for more information.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11461742.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related medicine news :

1. Dimension One Spas Receives Spa Certified Award for 2014
2. NetDimensions Enters the Nordic Market
3. Royal Caribbean Partners with NetDimensions to Deliver Shipboard Software Training
4. New Hires for Dimension One Spas
5. Infotool Hosts Dimensional Insight Users Conference for Nordic BI Customers
6. Dimension One Spas Introduces Driftwood Gray
7. Last Weekend for Dimension One Spas’ Annual Tailgate Event
8. Dimension One Spas Anticipates More Growth This Year
9. Symbiosis Gathering 2013 - A Multi-Dimensional Event
10. Dimension One Spas Unveils New Website July 2013
11. Mainz University obtains new CRC Nanodimensional polymer therapeutics for tumor therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... is common during the holidays, but there are strategies that ... "Don,t arrive at a party hungry. It may seem logical ... a party, but deprivation leads to hunger, and hunger leads ... in Mount Kisco, N.Y., said in a hospital news release. ... even to have a snack before attending a party when ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. ... on a "fountain of youth" drug that can delay the ... a new study suggests. Seniors received a significant boost ... a genetic signaling pathway linked to aging and immune function, ... The experimental medication, a version of the drug rapamycin, improved ...
(Date:12/25/2014)... Thousands of transvaginal mesh lawsuits ( ... number of multidistrict litigations currently underway in U.S. District ... reports. According to an Order issued on December 2, ... Status Conference in all of the proceedings on January ... to submit a proposed agenda to the Court by ...
(Date:12/25/2014)... 25, 2014 Plugin creators from Pixel ... A fully customizable business presentation tool made specifically for ... ProFire 5k business tool, users can now display their ... of Pixel Film Studios. “ProFire 5k gives users a ... add professionalism to a presentation” , Pixel Film Studios ...
(Date:12/25/2014)... Rosa, CA (PRWEB) December 25, 2014 ... department visits and 2 million hospital admissions across the ... and Prevention ). The CDC’s National Hospital Ambulatory ... departments through a survey conducted in 2010. They estimated ... department visits that resulted in a primary diagnosis of ...
Breaking Medicine News(10 mins):Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 3Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 4
... sure they,ve made the right choice , ... ... annual Medicare enrollment has ended, some Medicare Advantage beneficiaries can ... period. That information comes from Allsup , a leading ...
... Jan. 12 Acclarent, Inc., a leading,medical technology ... address conditions affecting the ear, nose and,throat, announced ... financing round.,Acclarent intends to use the proceeds to ... as on-going investment in product,development and clinical studies. ...
... recall of King Nut brand after Minn. officials find bacteria ... been sickened , , SUNDAY, Jan. 11 (HealthDay News) -- ... for two brands of peanut butter after health officials in ... a tub of peanut butter that is distributed to schools ...
... giving guests a reason to be cheerful by announcing a winter sale ... ... (PRWEB) January 11, 2009 -- The Linwood Group has revealed that it ... can access its first rate facilities., , ,From Christmas through to the ...
... Ohio-based manufacturer and long-standing leader in the development of ergonomic ... with a solution to a unique furnishing challenge it faced ... ... Bowling Green, OH (PRWEB) January 10, 2009 ...
... The Asthma and Allergy Foundation of America (AAFA) announces ... been appointed to the Council of the National Institute ... the National Institutes of Health (NIH), for a four-year ... provides a diverse perspective on science, health and the ...
Cached Medicine News:Health News:Medicare Advantage Open Enrollment Offers One-Time Chance to Change Your Mind: Allsup Outlines Rules for Switching Plans 2Health News:Medicare Advantage Open Enrollment Offers One-Time Chance to Change Your Mind: Allsup Outlines Rules for Switching Plans 3Health News:Medicare Advantage Open Enrollment Offers One-Time Chance to Change Your Mind: Allsup Outlines Rules for Switching Plans 4Health News:Medicare Advantage Open Enrollment Offers One-Time Chance to Change Your Mind: Allsup Outlines Rules for Switching Plans 5Health News:Acclarent, Inc. Closes $26 Million Financing 2Health News:Peanut Butter Recalled as Salmonella Search Continues 2Health News:Peanut Butter Recalled as Salmonella Search Continues 3Health News:Peanut Butter Recalled as Salmonella Search Continues 4Health News:Linwood Group Setting Price Benchmark for Alcohol Rehab 2Health News:BioFit 1Y Takes the Plunge to Fill Undersea Seating Role for NOAA 2Health News:Asthma & Allergy Foundation CEO Appointed to NIH Council 2
(Date:12/24/2014)... RALEIGH, N.C. , Dec. 23, 2014 /PRNewswire/ ... (NASDAQ: ENDP ) (TSX: ENL), and BioDelivery ... today that they have submitted a New Drug Application ... Food and Drug Administration (FDA).  Buprenorphine HCl Buccal Film ... enough to require daily, around-the-clock, long-term opioid treatment and ...
(Date:12/22/2014)... JUNCTION, N.J. , Dec. 22, 2014 /PRNewswire/ ... company marketing its CytoSorb® blood purification technology to ... surgery patients in 28 countries worldwide, today announced ... Russo , MD, FACS, as its Senior Vice ... Dr. Di Russo ...
(Date:12/22/2014)... 22, 2014 Apnea Sciences ( www.apneasciences.com ) ... Aliso Viejo , California.  Jimmy ... tremendous growth and worldwide expansion, a new facility with ... the anti snore cure have exceeded our expectations and ... are now in 23 countries and will be increasing ...
Breaking Medicine Technology:Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5
... to Show That Extended,Thromboprophylaxis Reduces VTE Risk ... 44% , PARIS, July 8, 2007 /PRNewswire-FirstCall/ ... (EXtended CLinical,prophylaxis in Acutely Ill Medical patients) ... in acutely ill medical patients,with reduced mobility ...
... Positive Phase IIa Clinical,Trial Results, First clinical ... in AM-Pharma's Pipeline , BUNNIK, The Netherlands, ... novel therapeutics to treat,infectious and inflammatory diseases, ... Phase IIa Alkaline Phosphatase (AP) trial,for patients ...
Cached Medicine Technology:New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 2New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 3New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 4New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 5New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 6AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 2AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 3AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 4AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 5
Kit for the Preparation of Technetium Tc 99m Sestamibi for injection...
Straight Tip, Measures from 0mm to 20mm in 1mm Increments, Readable on Both Sides, Thumbscrew Lock Holds Desired Setting; in Titanium....
Very fine, blunt tip....
... The e.cam duet Signature Series ... and PET FDG imaging applications. The system ... capability with the features and flexibility of ... in one unit.,The e.cam duet ...
Medicine Products: